Skip to main content
Premium Trial:

Request an Annual Quote

Microbial Existentialism

If a researcher takes a swab of your nose and finds a new species of bacteria, the discovery of which leads to the development of a new drug, do you deserve a cut of those profits, asks Carl Zimmer in The New York Times. More and more, bioethicists are asking questions about people's relationships with their microbiomes, Zimmer says. Mount Sinai School of Medicine bioethicist Rosamond Rhodes tells Zimmer that information on an individual's microbiome deserves the same protection of privacy as genetic information.

But granting a person's microbiome the same protection as their genetic information could prove tricky. "Microbes defy a simple notion of individuality. They are essential to our biology, and they travel with us from birth to death. Yet they also flow between us, and can be found in water, food and soil," Zimmer says. For right now, the most important thing, researchers say, is to be honest with participants involved in microbiome studies to make sure they have a realistic understanding about any research they're taking part in. However, Zimmer adds, if new drugs start emerging from the insights provided by these studies, it may be time to consider how the study participants can share in the benefits.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.